Castor Oil

Summary

Castor Oil (CHEMBL2109005) is an approved unknown (ATC A06AB05); indicated across 2 conditions including constipation disorder.

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Unknown
• ATC class: A06AB05
• Indications: 2 conditions
• Clinical trials: 8

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL2109005
Name	Castor Oil
Type	Unknown
Max phase	4
ATC	A06AB05

Also known as: Bimayou, Castor oil, emulsion, flavored, E-1503, FEMA NO. 2263, Ins no.1503, Ins-1503, Ricinus communis fibre oil, Ricinus communis oil, Ricinus communis seed oil, Ricinus zanzibarinus

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

2 indications (1 at ChEMBL trial phase 4). Phase below is the highest clinical-trial phase recorded for this drug against each disease — not the molecule’s overall approval status (that is in the Summary).

Indication	Trial phase	MONDO	EFO
constipation disorder	4	MONDO:0002203	HP:0002019

1 further indication record had no mapped disease name (EFO/MeSH-only) or were duplicates, and are omitted.

Clinical trials

Total trials: 8.

Phase distribution

Phase	Trials
Not specified	5
PHASE2	2
PHASE2/PHASE3	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT01206270	PHASE2/PHASE3	COMPLETED	Androgen for Leydig Cell Proliferation
NCT00141908	PHASE2	COMPLETED	Prevention of Preterm Delivery in Twin Pregnancies by 17 Alpha-hydroxyprogesterone Caproate
NCT04807543	PHASE2	COMPLETED	Effect of Progesterone on Latent Phase Prolongation in Patients With Preterm Premature Rupture of Membranes
NCT00244738	Not specified	COMPLETED	The Use of Castor Oil as a Labor Initiator in Post-date Pregnancies
NCT03958981	Not specified	COMPLETED	Castror Oil for Labor Induction in Women With Previous Cesarean Section
NCT05013151	Not specified	UNKNOWN	The Effect of Dates and Castor Oil on the Initiation of Spontaneous Labor in Primigravida Parturients
NCT05723900	Not specified	COMPLETED	Evaluation of Pulp Response to Castor Oil
NCT06841939	Not specified	COMPLETED	Effectiveness of Castor Oil in Preventing Formal Induction of Labour in a Tertiary Institution

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).